50 Results for "

30834

" in MedChemExpress (MCE) Product Catalog:
Products (50)

50 Results for "30834" in MCE Product Catalog:

6
6 Publications Verification
Cat. No.: HY-14814
CAS No.: 189279-58-1
Purity:  99.95%
Synonyms: RX-3341; WQ-3034; ABT492
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Delafloxacin (RX-3341; WQ-3034; ABT492) is a broad-spectrum fluoroquinolone antibiotic. Delafloxacin has a broad spectrum of activity that includes drug-resistant Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumonia .
6
6 Publications Verification
Cat. No.: HY-14814A
CAS No.: 352458-37-8
Purity:  99.87%
Synonyms: ABT492 meglumine; RX-3341 meglumine; WQ-3034 meglumine
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Delafloxacin meglumine (ABT492 meglumine; RX-3341 meglumine; WQ-3034 meglumine) is a broad-spectrum fluoroquinolone antibiotic. Delafloxacin has a broad spectrum of activity that includes drug-resistant Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumonia .
1
1 Cited Publications
Cat. No.: HY-15427
CAS No.: 1133432-49-1
Purity:  98.05%
Target:  

Btk

Research Areas:  

Inflammation/Immunology Cancer

GDC-0834 is an orally active selective, potent, and reversible BTK inhibitor with an IC50 of 5.9 nM. GDC-0834 demonstrates pBTK-Tyr223 inhibition in mice and rats. GDC-0834 can be used for research of rheumatoid arthritis (RA) .
Cat. No.: HY-15427A
CAS No.: 1133432-46-8
Target:  

Btk Drug Isomer

Research Areas:  

Inflammation/Immunology

GDC-0834 Racemate is the racemic form of GDC-0834 (HY-15427). GDC-0834 is an orally active selective, potent, and reversible BTK inhibitor with an IC50 of 5.9 nM. GDC-0834 demonstrates pBTK-Tyr223 inhibition in mice and rats. GDC-0834 can be used for research of rheumatoid arthritis (RA) .
Cat. No.: HY-177331
CAS No.: 1259029-47-4
Target:  

Integrin

Research Areas:  

Cardiovascular Disease

BTT-3034, a sulfonamide derivative, is an α2β1 integrin inhibitor. BTT-3034 inhibits cell adhesion to rat tail collagen I with an EC50 of 160 nM and a corresponding Emaxof 86%. BTT-3034 inhibits collagen binding by an α2 variant carrying the conformationally activating E318W mutation .
Cat. No.: HY-15427B
CAS No.: 1133432-50-4
Purity:  98.03%
Target:  

Btk

Research Areas:  

Others

GDC-0834 (S-enantiomer) is the S-enantiomer of GDC-0834. GDC-0834 is a potent and selective BTK inhibitor.
Cat. No.: HY-105298
CAS No.: 868741-81-5
Target:  

Angiotensin Receptor

Research Areas:  

Cardiovascular Disease

CR 3834 is a angiotensin-AT1 antagonist. CR 3834 can be used for the research of cardiovascular disease .
Cat. No.: HY-14814R
CAS No.: 189279-58-1
Synonyms: RX-3341 (Standard); WQ-3034 (Standard); ABT492 (Standard)
Research Areas:  

Infection

Delafloxacin (Standard) is the analytical standard of Delafloxacin. This product is intended for research and analytical applications. Delafloxacin (RX-3341; WQ-3034; ABT492) is a broad-spectrum fluoroquinolone antibiotic. Delafloxacin has a broad spectrum of activity that includes drug-resistant Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumonia .
Cat. No.: HY-R02955
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-3083-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-R02958
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-3084-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-R02959
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-3084-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-R02956
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-3083b-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-R02957
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-3083b-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-R04342
Target:  

MicroRNA

Research Areas:  

Cancer

rno-miR-3084a-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-R04343
Target:  

MicroRNA

Research Areas:  

Cancer

rno-miR-3084b-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-R04344
Target:  

MicroRNA

Research Areas:  

Cancer

rno-miR-3084b-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.
Cat. No.: HY-RI02956A
Target:  

MicroRNA

Research Areas:  

Cancer

mmu-miR-3083b-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
Cat. No.: HY-RI04342A
Target:  

MicroRNA

Research Areas:  

Cancer

rno-miR-3084a-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
Cat. No.: HY-RI04344A
Target:  

MicroRNA

Research Areas:  

Cancer

rno-miR-3084b-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
Cat. No.: HY-R04341
Target:  

MicroRNA

Research Areas:  

Cancer

rno-miR-3084a-1-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.